BENITEC BIOPHARMA LIMITED has not announced any capital raises, but we are collecting interest for future raises.
1. Create Account
Complete your onboarding digitally in less than 3 minutes.
2. View Terms
View the full term sheet for the capital raise.
3. Bid for Allocation
Submit and track your bid online.
Benitec Biopharma Limited (BLT) is a biotechnology company focused on the development of treatments for chronic and life-threatening human conditions based on its patented gene-silencing technology, ddRNAi. BLT has also licensed ddRNAi technology and other patent estate to other biopharmaceutical companies. The Company's current focus has been on its hepatitis C therapeutic, TT-034. Former Names Queensland Opals NL (QOP), 30/04/2002; Benitec Limited (BLT), 24/11/2011
1201/99 Mount St, North Sydney NSW 2060, Australia
Fresh Equities does not have BENITEC BIOPHARMA LIMITED quarterly cash flows data.
Fresh Equities does not have BENITEC BIOPHARMA LIMITED directors data.
Fresh Equities does not have BENITEC BIOPHARMA LIMITED announcements data.
Fresh Equities does not have BENITEC BIOPHARMA LIMITED news data.